President Trump threatened to levy a new 50% tariff on E.U.-imported goods last week. Novo Nordisk manufactures much of its GLP-1 drugs in Denmark. The president delayed implementation of the ...

Novo Nordisk (NYSE: NVO) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight loss market. As Reuters reports today, an online weight loss company ...

Novo Nordisk, the maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by "mutual agreement" with the company's board of directors, citing "recent market challenges ...

LONDON (Reuters) - Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing its first-mover advantage in the highly competitive ...

Despite Novo Nordisk's stock decline, the company's competitive position is strengthening, driven by strong sales growth in Wegovy, Ozempic, and rare diseases. Eli Lilly's oral weight-loss drug ...

Leticia Spiller, de 51 anos, compartilhou nas redes sociais no último domingo (16/03) uma foto ao lado de Franclim Mendes da Silva, apontado como seu novo romance. Os dois estavam no Jardim ...

Novo Nordisk announced launching a direct-to-patient online pharmacy NovoCare, offering a more than half-price cut for its weight-loss treatment Wegovy. Europe’s largest pharmaceutical firm ...

Carregando imagens... Foto 'mug shot' de Trump em 2023, e foto oficial divulgada para novo governo, em 2025 - Reuters/Trump War Room no X Comparações também foram feitas entre a foto de agora e ...

O internauta buscou no Google fotos de helicópteros com fundo transparente, em PNG, e encontrou a foto de uma aeronave igual a que aparece atrás de Davi Brito. Logo a imagem ganhou repercussão ...

Governo do Japão admitiu ter manipulado foto oficial do novo Gabinete para fazer seus membros parecerem menos desleixados — Foto: JIJI PRESS / AFP A foto oficial do novo Gabinete do Japão foi ...

Oct 7 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab and Viatris (VTRS.O), opens new tab have agreed to resolve a patent dispute related to Novo's blockbuster weight-loss drugs Ozempic and ...